When it comes to healthcare, personalization is key. According to a new survey by Verily and The Harris Poll, 75% of respondents would like an app that provides personalized health recommendations from a care provider and helps them better understand their health over time. Discover more insights from our "Consumer Survey on Personal Health Technology.”
We’re honored to introduce Jennifer Vachon, former EVP at Blue Cross Blue Shield Association (BCBSA), and Marty Webb, former VP Global Benefits at AT&T, as advisors to our business aimed at supporting our payer and employer clients. Their expertise will help us accelerate our mission of bringing precision health to everyone, every day. Jennifer was responsible for driving strategy and overseeing BCBSA national programs that collectively support over 115 million people, and is recognized for her leadership and community involvement. Marty is recognized for his innovative contributions to healthcare and retirement plans, including leading significant benefit design and merger initiatives. We are so excited to partner with Jennifer and Marty!
Invaluable insights at the ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop! Sylvia Si Ying Li, PhD, Verily Quantitative Scientist, discussed with fellow regulatory and biopharmaceutical experts how health tech and biopharma collaborate to advance patient-centric medical product development with digital endpoints. Key takeaways: → Adoption of digital endpoints across therapeutic areas is growing rapidly to enable objective, granular and real-world quantification of disease modification and patient experience. → AI/ML integration in clinical research emphasizes a holistic, data-driven approach for personalized medicine and patient-centric outcomes.
HLTH USA is all about fostering connections, and we can’t wait to meet you in Las Vegas. Stop by booth #3010 for conversations with Verily leaders and visionaries driving precision health.
At two recent international events – GLOWACON Expo Osaka 2025 and “Water, Health, and Competitiveness” — Robert Morfino, Verily Business Development Lead, highlighted the potential for wastewater testing to not only inform public health but also healthcare, pharma, and aviation. It requires moving past siloed data, connecting environmental insights with clinical surveillance, EHRs, mobility data, and others. At Verily, we’re working to solve this data challenge with a platform that enables multimodal analysis and insight generation, which complements our biosurveillance solution, Verily Sightline. Verily continues to support GLOWACON’s mission to promote the institutionalization of wastewater and environmental surveillance within public health systems, and to develop a global sentinel system for epidemic outbreaks. We are excited about the growing momentum globally, and are thankful to the @European Commission for the opportunity to represent the private sector in this important conversation!
Our CEO Stephen Gillett will be speaking at HLTH 2025! 🗓️ Tuesday, October 21 ⏰ 3:30 PM 📍 Pharma Stage Joined by Lydia Ramsey Pflanzer of Endpoints News, they’ll explore how AI-enhanced tools can drive engagement in preventative health and provide new learnings to fuel research.
Looking to boost your metabolism? According to Verily's Carolyn Bradner Jasik, MD, focusing on sustainable habits like prioritizing sleep and regular physical activity can make a big difference. It's not just about what you eat, but how you live. “Metabolism is the engine that makes your body go. It is influenced by the physical demands you place on it through activity and also your body makeup in terms of muscle mass.”
"You can't change healthcare if everyone's being polite!” In the latest Leadership Rounds podcast, Carolyn Bradner Jasik, MD, Verily Associate Chief Clinical Officer, Care Solutions, talked to Dr. Reena Pande about the power of healthy conflict in driving innovation in health tech. “The problem we’re trying to solve at Verily is how do we integrate AI into direct patient care, safely and effectively and ensure it works for the culture of clinicians? My role is launching our Lightpath care solution, which is essentially AI-enabled care for cardiometabolic disease. That’s my clinical expertise.”
Influential leaders and visionaries creating the next generation of healthcare are gathering at #HLTHUSA – and Verily will be there! Join us in Las Vegas from October 19-22 at booth #3010 for: ✨ Exclusive insights into our AI innovations powering personalized care ✨ Live demos of our personal AI health coach ✨ Conversations with our experts on how we’re redefining patient engagement Learn how you can connect with us at HLTH USA 2025.
Spicy questions and answers at the Oliver Wyman Health Innovation Summit this week! Carolyn Bradner Jasik, MD, our Associate Chief Clinical Officer, Care Solutions, participated in the “Hot Ones” panel sharing the opportunities for AI in care and Verily’s special sauce in our own AI-enabled care solution – Verily Lightpath. The discussion centered around responsible AI and what will be needed to ensure new technologies are safe and effective in order to transform health care.
